Welcome to the annual Accomplishments Report of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
This report highlights activities, events, honors and achievements at the OSUCCC – James during 2018. We believe that our exemplary faculty and staff, along with our devoted volunteers and community supporters, have furthered the momentum of Ohio State’s nationally recognized cancer program as we pursue our shared vision of a cancer-free world.
The report contains synopses of promising studies by our more than 340 cancer researchers, who collectively represent 11 of the 15 colleges at Ohio State and who had hundreds of their studies published in peer-reviewed medical journals, including more than 100 in journals with impact factors of 10 or above. It also highlights our success in landing large grants for cancer research, recruiting top scientists to our cancer program, earning prestigious external awards, and launching or continuing wide-ranging initiatives and projects that contribute to the global fight against cancer.
Our record of success over the last decade has been well documented in our past two five-year NCI surveys, after both of which we earned the highest descriptor of “exceptional” and retained the comprehensive cancer center (CCC) designation that we have maintained by competitive renewal since 1976. Our ability to convert scientific discoveries into innovative cancer care and prevention strategies has given us a reputation as one of the most translational cancer hospitals in the nation and has helped us earn the trust of the thousands of patients and families we serve, who consistently present us with satisfaction scores that rank among the nation’s highest.
Understanding that no cancer is routine because each patient’s malignancy is biologically unique, we strive to provide research-based and compassionate care that is specially tailored to each individual who comes to us for help. This is reflected in our 2018 Accomplishments Report. We hope you will find it interesting and informative.
William Farrar, MD
Interim CEO, James Cancer Hospital and Solove Research Institute
Raphael Pollock, MD, PhD
Director, The Ohio State University Comprehensive Cancer Center